SolanaSOL, coin
DevelopingETF

Injective Jumps Over 17% as 21Shares ETF Filing Adds 40%-60% Staking Target and Token Lands on Phantom

Crypto News reports Injective rose more than 17% after 21Shares updated its proposed Injective ETF filing with a 40%-60% staking target and Injective launched on Phantom.

Why it matters

A spot ETF that stakes a majority of its holdings would be a new shape for US crypto ETF filings, and a named administrator, transfer agent and cash custodian in BNY Mellon is the kind of infrastructure detail that usually precedes a launch attempt. The staking percentage and the Nasdaq ticker are both from a filing, not an approval, so the ETF is not confirmed; the price move has a single source and no independent confirmation of the move or its size.

Key facts

Injective price rose more than 17%.

17 %Reported by Crypto News (CryptoNews.net)

21Shares filed an S-1 update for a proposed Injective ETF covering a staking allocation of 40% to 60% of the fund's $INJ holdings.

Reported by Crypto News (CryptoNews.net)

The proposed ETF would stake between 40% and 60% of its $INJ holdings, adjustable based on liquidity requirements.

40 %Reported by Crypto News (CryptoNews.net)

The proposed ETF is expected to pursue a Nasdaq listing under the ticker TINJ.

Reported by Crypto News (CryptoNews.net)

The FTSE Injective Index would serve as the ETF's pricing benchmark.

Reported by Crypto News (CryptoNews.net)

BNY Mellon has been named administrator, transfer agent and cash custodian for the proposed ETF.

Reported by Crypto News (CryptoNews.net)

Injective launched on Phantom, letting users access and manage $INJ through a wallet in the Solana ecosystem.

Reported by Crypto News (CryptoNews.net)

The filing update does not confirm regulatory approval or establish a final launch date.

Reported by Crypto News (CryptoNews.net)

What happened

Crypto News reported that Injective rose more than 17% as the wider crypto market moved higher, with two developments cited as adding momentum: an updated S-1 filing from 21Shares for a proposed Injective ETF, and Injective's launch on the Phantom wallet in the Solana ecosystem. The 21Shares filing update sets out a plan to stake between 40% and 60% of the fund's $INJ holdings, with the allocation adjustable against liquidity requirements, and expects a Nasdaq listing under the ticker TINJ priced against the FTSE Injective Index, with BNY Mellon named administrator, transfer agent and cash custodian. The same outlet states the filing does not confirm regulatory approval or set a final launch date, and reports the Phantom integration as letting users access and manage $INJ through a wallet in the Solana ecosystem. No other outlet in the set reports the price move, the staking target or the Phantom launch, so each rests on Crypto News alone and no figure is corroborated.

How the story developed

  1. First report

    First report by Crypto News (CryptoNews.net)

    Injective Price Breaks Higher as ETF Staking Plans and Phantom Integration Fuel Market Buzz

    Crypto News (CryptoNews.net)

  2. Update

    Injective price rises more than 17% alongside broader market gains

    Crypto News attributes the move to the wider crypto market moving higher plus institutional and ecosystem developments.

    Crypto News (CryptoNews.net)

  3. Official statement

    21Shares updates Injective ETF S-1 filing with 40%-60% staking target

    The fund would stake between 40% and 60% of its $INJ holdings, adjustable for liquidity needs, with a Nasdaq listing under ticker TINJ and BNY Mellon as administrator, transfer agent and cash custodian.

    Crypto News (CryptoNews.net)

  4. Official statement

    Injective launches on the Phantom wallet

    Users can access and manage $INJ through Phantom, described as a leading wallet in the Solana ecosystem.

    Crypto News (CryptoNews.net)

Affected entities

Original sources

PublisherReportRolePublished
Crypto News (CryptoNews.net)
Aggregator
Injective Price Breaks Higher as ETF Staking Plans and Phantom Integration Fuel Market BuzzOriginal